The Fructosamine test is a blood test that measures the level of fructosamine, a compound formed when glucose binds non-enzymatically to serum proteins, predominantly albumin, in a process called glycation. Because serum proteins have a shorter lifespan of approximately two to three weeks compared to the 120-day lifespan of red blood cells used in HbA1c measurement, fructosamine reflects average blood glucose control over the preceding two to three weeks rather than the two to three month window assessed by HbA1c. This shorter retrospective window makes fructosamine a uniquely valuable monitoring tool in clinical situations where a shorter-term glucose assessment is required or where HbA1c measurement is unreliable or uninterpretable.
The process of protein glycation is directly proportional to the ambient blood glucose concentration over time, meaning higher average blood glucose produces proportionally higher fructosamine levels. Unlike HbA1c, which is influenced by red blood cell turnover, haemoglobin variants, and haematological conditions, fructosamine is based on serum protein glycation and is therefore free from haematological interference. However, fructosamine is sensitive to conditions that alter serum albumin concentration and protein turnover, including nephrotic syndrome, liver disease, thyroid disorders, and malnutrition, which must be considered when interpreting results.
In India, diabetes mellitus affects over 101 million adults and gestational diabetes affects a significant proportion of pregnancies, creating large clinical populations where reliable glycaemic monitoring is essential. Fructosamine fills an important monitoring niche in conditions including haemolytic anaemia, haemoglobin variants such as HbS and HbC common in certain Indian communities, pregnancy-related red cell changes, and situations requiring rapid assessment of the impact of recent treatment changes on glycaemic control. The test is performed on a small blood sample drawn from a vein and completed in under five minutes.
2
Doctors prescribe a Fructosamine test in the following situations:
Monitoring glycaemic control when HbA1c is unreliable or uninterpretable in patients with haemolytic anaemia, iron deficiency anaemia, sickle cell disease, thalassaemia, and other conditions altering red blood cell lifespan or haemoglobin structure where fructosamine provides an accurate and haematologically unconfounded assessment of short-term glucose control.
Assessing glycaemic management during pregnancy and gestational diabetes where the expanded red blood cell mass, shortened erythrocyte lifespan, and physiological haemodilution of pregnancy make HbA1c less reliable, and where the two to three week window of fructosamine is particularly valuable for detecting rapid glycaemic changes and assessing the impact of dietary and insulin adjustments on glucose control.
Evaluating the short-term impact of recent treatment changes in diabetic patients where a new medication, insulin regimen adjustment, or significant dietary modification has been made and where fructosamine can detect the resulting glycaemic improvement or deterioration within two to three weeks, far earlier than the three-month interval required before HbA1c would reflect the change.
Monitoring glycaemic control in patients with chronic kidney disease on dialysis where erythropoietin therapy, frequent blood transfusions, and dialysis-related factors significantly shorten red blood cell lifespan and render HbA1c unreliable, and where fructosamine provides a more accurate reflection of glycaemic status in this clinically important and growing patient population in India.
Screening for diabetes in settings where HbA1c measurement is unavailable or cost-prohibitive and where fructosamine offers an accessible alternative glycation-based marker that reflects glucose exposure over the preceding weeks and can identify individuals with persistent hyperglycaemia warranting further diagnostic evaluation.
Assessing glycaemic status in patients with haemoglobin variants prevalent in certain Indian ethnic groups where specific haemoglobin mutations interfere with standard HbA1c assay methods and produce falsely low or falsely high results that cannot be reliably used for diabetes monitoring without fructosamine as an alternative marker.
3
The Fructosamine test measures the concentration of glycated serum proteins in the blood, expressed in micromoles per litre (µmol/L). The normal reference range for non-diabetic adults is 200 to 285 µmol/L, though reference ranges may vary slightly between laboratory platforms and are influenced by serum albumin concentration.
Normal (200 to 285 µmol/L)
A result within the normal range indicates that average blood glucose over the preceding two to three weeks has been within the non-diabetic range, consistent with good glycaemic control in a known diabetic patient or no significant hyperglycaemia in a patient being screened. Clinical correlation with fasting glucose, postprandial glucose, and symptoms of hypo or hyperglycaemia remains essential for complete diabetes management assessment.
Mildly Elevated (286 to 320 µmol/L)
A mildly elevated fructosamine suggests suboptimal glycaemic control over the preceding two to three weeks, corresponding approximately to an average blood glucose in the prediabetic to mildly diabetic range. In a known diabetic patient, this finding indicates that current dietary, lifestyle, or pharmacological management requires review and adjustment, and that closer monitoring and earlier follow-up are warranted.
Markedly Elevated (Above 320 µmol/L)
A markedly elevated fructosamine indicates poor glycaemic control with sustained significant hyperglycaemia over the preceding two to three weeks, corresponding to an average blood glucose well above target range. In diabetic patients, this finding requires prompt medical review, intensification of antidiabetic therapy, dietary counselling, and assessment for diabetes-related complications that may be accelerated by ongoing poor glycaemic control.
4
Fasting for 8 to 10 hours before the Fructosamine test is recommended, as recent food intake transiently elevates blood glucose and can influence fructosamine levels when testing is performed very shortly after a large carbohydrate-rich meal. Morning collection after an overnight fast is the standard and preferred approach, particularly when fructosamine is ordered alongside fasting glucose and other metabolic parameters as part of a comprehensive diabetes monitoring panel.
Inform your doctor about any recent acute illnesses, significant changes in diet, weight, or physical activity, or recent hospitalisations in the preceding two to three weeks, as these events directly influence the blood glucose profile over the fructosamine measurement window and must be factored into accurate clinical interpretation of the result to avoid misattributing a transiently elevated or lowered fructosamine to the underlying long-term glycaemic trend.
Inform your doctor about conditions that alter serum protein levels before the test, including nephrotic syndrome, liver cirrhosis, malnutrition, hyperthyroidism, and hypothyroidism, as these conditions alter albumin concentration and protein turnover and can produce fructosamine results that do not accurately reflect glycaemic status independent of blood glucose levels. If you are undergoing serial fructosamine measurements to monitor treatment response, consistent fasting conditions and use of the same laboratory platform ensures reliable trend comparison across visits. Staying well hydrated before the blood draw facilitates easier venous access and a smooth collection experience.
5
If you are booking through the SecondMedic platform the Fructosamine test price in Anand can cost you around Rs. 334. You may also consider booking a comprehensive diabetes monitoring panel that includes Fructosamine alongside fasting glucose, postprandial glucose, HbA1c where appropriate, and kidney function tests for a complete assessment of glycaemic control and diabetic complication risk at a bundled price on SecondMedic.
6
SecondMedic offers convenient home sample collection for the Fructosamine test in Anand, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained phlebotomist will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your blood sample is processed at NABL-accredited partner laboratories, and your report is delivered within 24 hours directly to your WhatsApp and email.
Yes, the Fructosamine test is fully available in Anand through SecondMedic. You can book online and a trained phlebotomist will collect your sample at home at your preferred time.
The Fructosamine test price in Anand on the SecondMedic platform is approximately Rs. 334. Prices may vary slightly based on the package selected at the time of booking.
Your Fructosamine test report will be delivered within 24 hours of sample collection. Reports are shared directly to your WhatsApp and email for easy and immediate access.
Samples collected in Anand are processed at NABL-accredited partner laboratories. This ensures accuracy, reliability, and strict adherence to national diagnostic quality standards.
Yes, home sample collection for the Fructosamine test is available in Anand. A certified phlebotomist will visit your address at a time slot that is most convenient for you.
Yes, home collection is available seven days a week in Anand, including Sundays and public holidays, between 7 AM and 10 PM without any additional charges.
Doctors prescribe this test to monitor glycaemic control when HbA1c is unreliable due to haematological conditions, assess glucose management during pregnancy and gestational diabetes, evaluate rapid treatment response changes, and monitor diabetic patients on dialysis where erythropoietin and transfusions make HbA1c inaccurate.
The normal fructosamine range for non-diabetic adults is 200 to 285 µmol/L. Values between 286 and 320 µmol/L indicate suboptimal control, while values above 320 µmol/L indicate poor glycaemic control over the preceding two to three weeks requiring prompt medical review and treatment intensification.
An elevated fructosamine indicates sustained hyperglycaemia over the preceding two to three weeks reflecting inadequate glycaemic control in a diabetic patient or significant glucose intolerance in a patient being screened. Your doctor will correlate findings with fasting glucose, clinical symptoms, albumin levels, and recent medication or lifestyle changes to determine the most appropriate adjustment to diabetes management.
Content Reviewed By
Reviewed by:
Dr. Kovid Pandey
MBBS, General Physician
Last Reviewed: 10th Mar 2026
References
1
American Diabetes Association: Standards of Medical Care in Diabetes, Diabetes Care, 2024
— doi.org
2
Sinh P et al.: Limitations of HbA1c as a Diagnostic Tool for Diabetes Mellitus in Persons with Anaemia, Journal of Diabetes Science and Technology, 2011
— doi.org
3
National Institute of Diabetes and Digestive and Kidney Diseases: Diabetes Tests and Diagnosis, NIDDK Health Information, 2023
— www.niddk.nih.gov
4
Kilpatrick ES et al.: Fructosamine versus Glycated Haemoglobin as a Measure of Glycaemic Control in Diabetes, Annals of Clinical Biochemistry, 1994
— doi.org